Renzi; Paolo

Patent Applications and Registrations

Patent applications and USPTO patent grants for Renzi; Paolo.The latest application filed is for "antisense oligonucleotides for treating allergy and neoplastic cell proliferation".

Company Profile

0.8.13

Renzi; Paolo - Westmount CA
Renzi; Paolo - Westmoutn CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antisense oligonucleotides for treating allergy and neoplastic cell proliferation Grant 8,202,851 - Renzi , et al. June 19, 2	2012-06-19
Oligonucleotide compositions and methods for treating disease including inflammatory conditions Grant 8,173,796 - Renzi , et al. May 8, 2	2012-05-08
Antisense Oligonucleotides For Treating Allergy And Neoplastic Cell Proliferation App 20120065249 - Renzi; Paolo ; et al.	2012-03-15
Antisense oligonucleotides for treating allergy and neoplastic cell proliferation Grant 8,119,790 - Renzi , et al. February 21, 2	2012-02-21
Oligonucleotides affecting expression of phosphodiesterases Grant 7,982,028 - Renzi , et al. July 19, 2	2011-07-19
Oligonucleotides Affecting Expression Of Phosphodiesterases App 20110086901 - Renzi; Paolo ; et al.	2011-04-14
Oligonucleotide Compositions And Methods For Treating Disease Including Inflammatory Conditions App 20110079528 - Renzi; Paolo ; et al.	2011-04-07
Antisense Oligonucleotides For Treating Atopic Diseases And Neoplastic Cell Proliferation App 20100286239 - Renzi; Paolo	2010-11-11
Methods For Increasing In Vivo Efficacy Of Oligonucleotides And Inhibiting Inflammation In Mammals App 20100286235 - RENZI; Paolo ; et al.	2010-11-11
Oligonucleotide compositions and methods for treating disease including inflammatory conditions Grant 7,825,236 - Renzi , et al. November 2, 2	2010-11-02
Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals Grant 7,745,420 - Renzi , et al. June 29, 2	2010-06-29
Oligonucleotides Affecting Expression Of Phosphodiesterases App 20100048673 - Renzi; Paolo ; et al.	2010-02-25
Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation Grant 7,629,324 - Renzi December 8, 2	2009-12-08
Antisense oligonucleotides for treating allergy and neoplastic cell proliferation App 20090215861 - Renzi; Paolo ; et al.	2009-08-27
No-donating corticosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties App 20090088411 - Renzi; Paolo ; et al.	2009-04-02
Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease App 20090087425 - Renzi; Paolo ; et al.	2009-04-02
Oligonucleotide Compositions And Methods For Treating Disease Including Inflammatory Conditions App 20090029938 - Renzi; Paolo ; et al.	2009-01-29
Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation App 20050282762 - Renzi, Paolo	2005-12-22
Cellular virus receptors and methods of use App 20050101530 - Renzi, Paolo ; et al.	2005-05-12
Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals App 20050032723 - Renzi, Paolo ; et al.	2005-02-10
Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation Grant 6,822,087 - Renzi November 23, 2	2004-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.